Stocks · Health care · Biological Products, (No Diagnostic Substances)

Neumora Therapeutics, Inc.

NMRA Clue Score21

United States Fiscal year ends December CIK 0001885522 Results filed 14 Aug 2026

Add to watchlist

What the insiders did Net buying

Bought (120 mo)

$133.55M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$3.77M

$2.62M on a plan · $1.07M straight out of an exercise

Sold at will

$77.47K

3 of 32 sales

Net

+$129.78M

+$133.47M against sales at will